Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Second Generation 4-1Bbζ Egfr806-Egfrt
Hepatocellular Carcinoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt
Ewing Sarcoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt
Neuroblastoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt
Osteosarcoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt
Soft Tissue Sarcoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg
Hepatocellular Carcinoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg
Ewing Sarcoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg
Neuroblastoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg
Osteosarcoma
Seattle Children's Hospital
P1
CC
(41)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg
Soft Tissue Sarcoma
Seattle Children's Hospital
P1
CC
(41)
Senl101
T-Cell Non-Hodgkin Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.
P1
CC
(41)
Stapuldencel
T-Cell Acute Lymphoblastic Leukemia
Shenzhen Geno-Immune Medical Institute
P1
CC
(41)
Super Car-T
Hepatocellular Carcinoma
Guangzhou FineImmune Biotechnology Co., LTD.
P1
CC
(41)
Synkir-110, Autologous T Cells Transduced With Mesothelin Kir-Car
Malignant Mesothelioma
Verismo Therapeutics
P1
CC
(41)
tcr1020-cd8 t cells
Pancreatic Adenocarcinoma
University of Pennsylvania
P1
CC
(41)
Tcr-T Cells
Pancreatic Neoplasm
Beijing DCTY Biotech Co.,Ltd.
P1
CC
(41)
Tcr-T Cells
Neoplasm
Sun Yat-sen University
P1
CC
(41)
tm123
Acute Myeloid Leukemia
AvenCell Therapeutics, Inc.
P1
CC
(41)
Tnhyp217 Car T Cells
Colonic Neoplasm
National Cancer Institute (NCI)
P1
CC
(41)
Tnhyp217 Car T Cells
Mesothelioma
National Cancer Institute (NCI)
P1
CC
(41)
Tnhyp217 Car T Cells
Pancreatic Neoplasm
National Cancer Institute (NCI)
P1
CC
(41)
Tnhyp217 Car T Cells
Gastric Neoplasm
National Cancer Institute (NCI)
P1
CC
(41)
Tsc-200-A0201
Oropharynx Squamous Cell Carcinoma
TScan Therapeutics, Inc.
P1
CC
(41)
Tsc-200-A0201
Cervical Adenocarcinoma
TScan Therapeutics, Inc.
P1
CC
(41)
Tsc-200-A0201
Adenosquamous Carcinoma
TScan Therapeutics, Inc.
P1
CC
(41)
Showing 1976 to 2000 of 3,186 assets
Previous
Page 80 of 128
Next
